Page 20 - Sebi

Sebi bars Nirman Agri Genetics, promoter for alleged misuse of IPO funds

Sebi has called for a detailed investigation and given the company and promoter 21 days to file their objections or request a hearing

Renewal of trustees' term in focus at Tata Trusts amid ongoing tension

Trustees at Dorabji Tata Trust, the key trust which along with Sir Ratan Tata Trust own a majority of share in Tata Sons, have had a three-year term

Trustees must act fearlessly, build guardrails for MF industry: Sebi chief

Tuhin Kanta Pandey urges mutual fund trustees to set up early warning systems, strengthen oversight, and avoid passive compliance to protect investors

Sebi developing tools to curb fraudulent trades: Tuhin Kanta Pandey

Regulator to float consultation papers on MIIs guidelines, easier KYC for NRIs

Google to introduce verification tick for registered broking apps: Sebi WTM

Sebi has directed Google to add verification tick marks for registered broking apps on Play Store within two months to curb fraudulent trading platforms and protect investors

Sebi runs lean again as two whole-time member positions remain vacant

Extended gaps in board appointments raise concerns over continuity, policy direction, and adjudication at the capital markets regulator

Sebi, bourses align penalty framework to ease brokers' compliance

New Sebi framework aims to reduce duplication of penalties, bring uniformity across exchanges, and ease compliance for brokerage firms

Indian investors remain risk-averse, Sebi urges diversified portfolios

Sebi's 2025 survey finds most Indians prioritise capital preservation; experts say align risk with time horizon and personal comfort level

Integris Medtech files IPO papers with Sebi to garner ₹3,500-4,000 cr

Integris Medtech, a diversified medical technology platform, has filed preliminary papers with markets regulator Sebi to raise funds through an initial public offering (IPO), with people familiar with the matter pegging the issue size between Rs 3,500 crore and Rs 4,000 crore. With this, the company, which manufactures and distributes cardiac stents, is eyeing a valuation of Rs 11,000-13,000 crore, they added. According to the draft red herring prospectus (DRHP) filed on Thursday, Integris Medtech's IPO comprises a fresh issue of equity worth Rs 925 crore and an offer for sale of 2.16 crore equity shares by promoters. As part of the OFS, Evercure Holdings Pte Ltd, Gurmit Singh Chugh, and Punita Sharma will offload shares. Proceeds of the fresh issue will primarily be used for payment of debt and general corporate purposes. Backed by private equity player Everstone Capital, Integris Medtech may consider a pre-IPO placement for up to Rs 185 crore. If such placement is completed, the

SC to hear MP Mahua Moitra's plea to mandate disclosure of FPIs on Oct 14

The Supreme Court on Thursday said it would hear on October 14 TMC MP Mahua Moitra's plea to mandate public disclosure of ultimate beneficial owners and portfolios of alternative investment funds (AIFs), foreign portfolio investors and their intermediaries in India. The plea came up for hearing before a bench of Justices B V Nagarathna and R Mahadevan. Advocate Prashant Bhushan, appearing for Moitra, said they have filed the reply received from the Securities and Exchange Board of India (SEBI) on the detailed representation made by the petitioner on the issue. The top court on April 1 asked Moitra to make a detailed representation to the SEBI on the issue. Bhushan said they have also filed their response to the reply received from SEBI last month. "You amend your writ petition," the bench said. Bhushan, while referring to the prayer made in the plea, said the SEBI's response to the representation does not answer the problem. He said amending the petition was not necessary as the

Ex-trader Ananth Narayan, who led Jane Street probe, ends term at Sebi

Narayan, who has spent more than two decades at global banks including Standard Chartered Plc, has been a driving force behind the charges against Jane Street

Sebi preparing action plan for quantum-safe computing: Tuhin Kanta Pandey

Chairman Tuhin Kanta Pandey says quantum advances could break today's encryption; Sebi aims password protection, stronger AI oversight, and fraud prevention

Sebi proposes reforms to streamline IPF, tighten bourse regulations

Key proposals include merging equity and commodity IPFs, introducing a three-year limit on investor claims, and tightening norms for exclusively listed firms

Sebi eases norms for block deal window, allows same-day settlement

The market regulator has introduced dual trading windows and set a ₹25-crore minimum order size for block deals to enhance execution efficiency and liquidity

Sebi to review SLB framework for wider user participation: Ananth Narayan G

Whole-time member Ananth Narayan says Sebi aims to improve design and process efficiency for SLB trades, boosting participation and cash market depth

Sebi to deploy AI tool to track misleading ads, finfluencer content

Sebi is deploying an AI tool, R(AI)DAR, to track misleading ads and finfluencer content, enhancing investor protection and monitoring social media for illegal financial promotions

Sebi flags 100k misleading social media posts amid investor scams

Sebi identified over 100,000 unlawful social media posts in 18 months, unveiling new tools to curb scams and boost investor awareness across India

Lenskart Solutions, Wakefit, four others get Sebi nod to float IPOs

Tenneco Clean Air India, Waterways Leisure Tourism, the operator of Cordelia Cruises; Shree Ram Twistex and Lamtuf are among the companies that have received regulatory approval

Bombay HC seeks Sebi response on plea alleging irregularities in WeWork IPO

Bombay HC has sought Sebi's response on a plea challenging WeWork India's IPO, alleging irregularities in DRHP, undisclosed complaints, and misrepresentation of ties with the global WeWork brand

Upcoming IPO! Advit Jewels files draft papers with Sebi; check key details

The maiden offering of Advit Jewels will comprise an entirely fresh issue of equity shares, with no offer for sale (OFS) component